Michael Merger
Impact in
- Gastroenterology top 5%
- Gastrointestinal motility and disorders
- Immunology top 10%
- Immune Cell Function and Interaction
- Immune Response and Inflammation
- Immune cells in cancer
- T-cell and B-cell Immunology
Papers in
-
- Renal cell carcinoma treatment 3
-
- Gastrointestinal motility and disorders 3
- Celiac Disease Research and Management 2
- Co-authors
- H. Kilbinger (1 shared paper)Alexander Gebauer (1 shared paper)Phillip D. Smith (2 shared papers)Martin F. Graham (2 shared papers)Jan M. Orenstein (2 shared papers)Michael W. Russell (1 shared paper)Hiromi Kubagawa (1 shared paper)Toshihide Shimada (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Gut (2 papers)Molecular Cancer Therapeutics (1 paper)The Journal of Immunology (1 paper)Journal of Immunological Methods (1 paper)
- Partner nations
- GermanyFranceUnited States
In The Last Decade
Michael Merger
20 papers receiving 980 citations
Peers
Comparison fields: 5 of 82
- Gastroenterology 85
- Immunology 313
- Reproductive Medicine 100
- Virology 37
- Oncology 147
Countries citing papers authored by Michael Merger
This map shows the geographic impact of Michael Merger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Merger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Merger more than expected).
Fields of papers citing papers by Michael Merger
This network shows the impact of papers produced by Michael Merger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Merger. The network helps show where Michael Merger may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Merger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 282 | |
| 2 | 2011 | 175 | |
| 3 | 1993 | 123 | |
| 4 | 1997 | 90 | |
| 5 | 2002 | 89 | |
| 6 | 2012 | 71 | |
| 7 | 2002 | 46 | |
| 8 | Phase II trial of weekly alternating sequential BIBF 1120 and afatinib for advanced colorectal cancer. | 2011 | 37 |
| 9 | 1999 | 31 | |
| 10 | 1998 | 17 | |
| 11 | Prolactin stimulates proliferation of the glucose-dependent beta-cell line INS-1 via different IRS-proteins. | 2007 | 17 |
| 12 | 2006 | 12 | |
| 13 | 2014 | 12 | |
| 14 | 2018 | 8 | |
| 15 | 2014 | 5 | |
| 16 | 2019 | 2 | |
| 17 | 2008 | 2 | |
| 18 | 2017 | 1 | |
| 19 | 2005 | 1 | |
| 20 | 2012 | 1 |
About Michael Merger
Michael Merger is a scholar working on Pulmonary and Respiratory Medicine, Gastroenterology, Reproductive Medicine, Infectious Diseases and Surgery, having authored 21 papers that have together received 1.0k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (4 papers), Renal cell carcinoma treatment (3 papers), Gastrointestinal motility and disorders (3 papers), Celiac Disease Research and Management (2 papers), Radiomics and Machine Learning in Medical Imaging (2 papers), Microscopic Colitis (2 papers), Immune Response and Inflammation (2 papers) and Streptococcal Infections and Treatments (1 paper). The work is most often cited by research in Gastroenterology (85 citations), Immunology (313 citations), Reproductive Medicine (100 citations), Virology (37 citations) and Oncology (147 citations). Michael Merger has collaborated with scholars based in Germany, France and United States. Frequent co-authors include H. Kilbinger, Alexander Gebauer, Phillip D. Smith, Martin F. Graham, Jan M. Orenstein, Michael W. Russell, Hiromi Kubagawa, Toshihide Shimada, Meg Mosteller‐Barnum and Don A. Sibley. Their work appears in journals such as Journal of Clinical Oncology, Gut, Molecular Cancer Therapeutics, The Journal of Immunology and Journal of Immunological Methods.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.